Lataa...
Treatment of inflammatory myopathy: emerging therapies and therapeutic targets
Despite the lack of placebo-controlled trials, glucocorticoids are considered the mainstay of initial treatment for idiopathic inflammatory myopathy and myositis-associated interstitial lung disease. Glucocorticoid-sparing agents are often given concomitantly with other immunosuppressive agents, par...
Tallennettuna:
| Julkaisussa: | Expert Rev Clin Immunol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864492/ https://ncbi.nlm.nih.gov/pubmed/26313852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2015.1082908 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|